Search
Sumario de resultados
TIpos de contenido
Fecha
-
New#InterviewBiospain2021 | "Biospain should be an inspiring event that motivates emerging bi...
We spoke with Karen Wagner, General Partner of Ysios Capital, Gold sponsor de Biospain 2021, about our international benchmark event and the strengths and weaknesses of the Spanish biotech sector
-
New#InterviewBiospain2021 | Asabys, leading Spanish health investor accredited for its commit...
We spoke with Clara Campàs and Josep Lluís Sanfeliu, founders of Asabys Partners venture capital, silver sponsor of BioSpain 2021, about their commitment to sustainability and the future of
-
Ally
Eversheds Sutherland
At Eversheds Sutherland we are aware of the special complexity of business activities in the health sector, where institutional, regulatory, trade and legal issues converge on a daily basis in a
-
CompanyIOMED Medical Solutions SL
-
CompanyDIVERSA Technologies
-
EventAdvanced Biocatalysis Workshop
A free virtual event for the very latest innovations, insights and trends in biocatalysis.
-
NewWhole Genome Sequencing :The Future Is Now
What was once only a futuristic vision has become reality for patients and physicians seeking answers for a rare disease. Learn how whole genome sequencing can be deployed to hunt for a diagnosis and
-
CompanyIntegra Therapeutics S.L.
-
CompanyFlomics Biotech
-
Press releasePandemic consolidates the trend of job and talent growth in the biotech sector
Biotech companies are expanding their workforce amid the pandemic, accentuating in 2020 the growth trend of recent years, in which staff increased by 7.6% in 2019 and accounted for 12.8% of people
-
Press releaseBIOSPAIN represents a boost for investment in a decisive year for biotechnology
The pandemic has provided an opportunity for Spanish biotechnology and private investment has increased by 50% in 2020. BIOSPAIN 2021, the reference Spanish trade fair for investment agents and
-
Press releaseMore than 160 spanish biotech companies seek out solutions for a greener industry
Most of these companies will be at the most important annual event for the sector, BIOSPAIN 2021, which will be held in Pamplona-Iruña from 27th September to 1rst October
-
Press release2020 AseBio Report shows huge jump in Spanish biotechnology in pandemic year
Biotech companies launched 70% more products and services to market and Spain moved to eighth in the world in scientific production in biotechnology
-
Press releasePersonalised medicine increases its activity by 40% in the last year and is becoming more ...
Precision medicine and personalised medicine products or services have gone from representing 12% of total launches to 52% in 2020. Navarra, which is hosting Biospain 2021, is one of the pioneering
-
-
NewORYZON reports results and corporate update for first half ended June 30, 2021
Oryzon Genomics, S.A., the Spanish company developing innovative epigenetic experimental therapies, announces results and progress in the first half of 2021
-
NewImmunostep develops a new serological test capable of differentiate vaccinated individuals...
The company announced the launch of a new antibody test that detects three types of antibodies against four proteins of the SARS-CoV-2 virus with a single blood sample and 99% of reliability
-
NewPETRA: The potencial of medical robots
The robot facilitates thyroid diagnosis by interacting with humans and making an assessment based on preset parameters
-
NewTECNIC Bioprocess Equipment Manufacturing presents the new range of ePILOT bioreactors
The new ePILOT bioreactors, ranging from 10 to 50 litres in useful volume, feature an extremely compact design ideal for tight spaces.
-
NewLaboratorios Rubio continues with its international expansion plan
Laboratorios Rubio S.A has submitted to the FDA all the documentation for the registry of 2 blood sample based diagnostic tests, as first step with its international expansion strategy
-
NewAyming for the best version of Spanish biotechnology
Biocompanies are synonymous of innovation and transformation, as they have always outlined each area of their activity in order to concentrate talent, new technologies and research